Table 4 P. falciparum CSP positivity of Anopheles gambiae s.s. identified to both molecular and chromosomal form. Status as M molecular form and Mopti chromosomal form was significantly associated with CSP positivity in October 2009 ( P = 0.001)
No. CSP Pos. / No. Screened (% Pos.) | ||||
|---|---|---|---|---|
Chromosomal Form | Molecular Form | Total | ||
M | S | M/S | ||
Kela | ||||
Bamako | 0/0 (0%) | 11/117 (9.4%) | 0/1 (0%) | 11/118 (9.3%) |
Savanna | 2/6 (33.3%) | 5/10 (50.0%) | 0/0 (0%) | 7/16 (43.8%) |
Mopti | 6/38 (15.8%) | 0/1 (0.0%) | 0/0 (0%) | 6/39 (15.4%) |
Total | 8/44 (18.2%) | 16/128 (12.5%) | 0/1 (0%) | 24/173 (13.9%) |
Sidarebougou | ||||
Bamako | 0/0 (0.0%) | 0/2 (0%) | 0/0 (0.0%) | 0/2 (0.0%) |
Savanna | 1/13 (7.7%) | 15/108 (13.9%) | 1/4 (25.0%) | 17/125 (13.6%) |
Mopti | 5/19 (26.3%) | 0/1 (0%) | 0/0 (0.0%) | 5/20 (25.0%) |
Total | 6/32 (18.8%) | 15/111 (13.5%) | 1/4 (25.0%) | 22/147 (15.0%) |
Mali | ||||
Bamako | 0/0 (0.0%) | 11/119 (9.2%) | 0/1 (0.0%) | 11/120 (9.2%) |
Savanna | 3/19 (15.8%) | 20/118 (16.9%) | 1/4 (25.0%) | 24/141 (17.0%) |
Mopti | 11/57 (19.3%) | 0/2 (0.0%) | 0/0 (0.0%) | 11/59 (18.6%) |
Total | 14/76 (18.4%) | 31/239 (13.0%) | 1/5 (20.0%) | 46/320 (14.4%) |